This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Morphic Therapeutic, Inc., Nimbus Clio, Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Salma Rafi: Innovator in Therapeutic Compounds
Introduction
Salma Rafi is a distinguished inventor based in Lexington, MA (US). She has made significant contributions to the field of therapeutic compounds, holding a total of 3 patents. Her work focuses on innovative solutions for various medical conditions.
Latest Patents
Among her latest patents is the invention titled "CBL-B modulators and uses thereof." This invention provides compounds and methods for inhibiting Cbl-b, which is crucial for treating Cbl-b-mediated disorders. Another notable patent is related to "Inhibiting human integrin (alpha-4) (beta-7)," which discloses small molecule antagonists of human integrin and their applications in treating various diseases and conditions.
Career Highlights
Salma has worked with prominent companies in the biotechnology sector, including Morphic Therapeutics, Inc. and Nimbus Clio, Inc. Her expertise and innovative approach have positioned her as a key player in the development of new therapeutic strategies.
Collaborations
Salma has collaborated with talented individuals such as Matthew Gregory Bursavich and Dan Cui, contributing to the advancement of her research and inventions.
Conclusion
Salma Rafi's contributions to the field of therapeutic compounds highlight her innovative spirit and dedication to improving healthcare solutions. Her patents and collaborations reflect her commitment to advancing medical science.